Swecure Overview
- Year Founded
-
2013

- Status
-
Out of Business
- Employees
-
5

- Latest Deal Type
-
Out of Business
- Investors
-
1
Swecure General Information
Description
Developer of bacterial therapeutics treatments designed to treat immunoregulatory disorders, such as allergy and IBD. The company's treatments are based on extensive studies on the correlations between certain bacteria in the microbiome and disease development later in life, enabling people with immunoregulatory disorders to improve quality of life.
Contact Information
Primary Industry
Biotechnology
Primary Office
- Stureplan 15
- 111 45 Stockholm
- Sweden
Swecure Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Jan-2020 | Completed | Out of Business | |||
2. Early Stage VC | Completed | Startup | ||||
1. Accelerator/Incubator | Completed | Startup |
Swecure Patents
Swecure Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-2995314-A1 | Use of collinsella for treatment of inflammatory bowel disease | Inactive | 12-Sep-2014 | 0000000000 | 0 |
US-20180028579-A1 | Use of collinsella for treatment of inflammatory bowel disease | Inactive | 12-Sep-2014 | 0000000000 | |
CA-2574093-A1 | Prevention of allergy in children | Active | 16-Jul-2004 | 0000000000 | |
CA-2574093-C | Prevention of allergy in children | Inactive | 16-Jul-2004 | 0000000000 | |
DE-602005023184-D1 | Prevention of allergy in children | Active | 16-Jul-2004 | A61K39/085 |
Swecure Signals
Swecure Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Hargay | Asset Manager | Minority | 000 0000 | 000000 0 |